Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveNovartis halts mid-stage trial for kidney drug, Fabhalta, in lupus nephritis

Live News NEWS FLASH L impact Oct 16, 2026, 06:00 PM UTC

Novartis halts mid-stage trial for kidney drug, Fabhalta, in lupus nephritis

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

US Secretary of State Marco Rubio L impact | NEWS | Oct 21, 2026, 04:11 AM UTC Saudi-led coalition: drones intercepted and destroyed in Medina and eastern areas, spokesperson says L impact | NEWS | Oct 21, 2026, 03:55 AM UTC Saudi-led coalition: four drones targeting Saudi Arabia intercepted and destroyed, coalition spokesperson L impact | NEWS | Oct 21, 2026, 03:53 AM UTC South Korean President Lee: Government preparing to reduce mandatory domestic fuel supply, allow refiners to increase exports L impact | NEWS | Oct 21, 2026, 03:18 AM UTC Asia FX Updates: Australian Dollar Increases by 0.38% Top currency gainers are Australian Dollar (0.38%) and South Korean Won (0.10%). Biggest loser is Indian Rupee (-0.37%). Meanwhile, Chinese Yuan and Japanese Yen were little change L impact | NEWS | Oct 21, 2026, 02:15 AM UTC Trump: Pentagon to invest $1.5 billion in semiconductor chip production in North Carolina L impact | NEWS | Oct 21, 2026, 12:40 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.